Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

MYSTERIOUS: Cencora earnings preview what to expect cqfgah7m - You Need To See This

With a market cap of $59.9 billion, Cencora, Inc. (COR) is a leading global pharmaceutical solutions organization dedicated to improving the lives of people and animals worldwide. By partnering with pharmaceutical innovators and healthcare providers, the company enables secure, reliable access to therapies and healthcare solutions while advancing healthier futures.

The Conshohocken, Pennsylvania-based company is slated to announce its fiscal Q3 2026 results before the market opens on Wednesday, Aug. 5. Ahead of the event, analysts forecast Cencora to report an adjusted EPS of $4.37, up 9.3% from $4 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in three of the past four quarterly reports while missing on another occasion.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.